what could go wrong?, page-56

I suspect what Neo is on about may well be contributing to the lack of movement in the share price. Most of the excitement was around the time the trial should have been completed. Now that we are in the "Too good to be true" zone people are worrying.

You have to admit though Neo, most of your argument is based around what you perceive to be the companies expectations. They may internally have more confidence than that they have published. It would have been a little risky for them to come out before the trial saying they where expecting an improvement of 13 months when 6 weeks is enough for the FDA. It's also high time Alchemia surprised to the upside.

Gosh, and I thought you were negative when you held the stock!